PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532895
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532895
Guided Bone Regeneration Market size was valued at USD 760.90 Million in 2023, expanding at a CAGR of 4.69% from 2024 to 2032.
Guided bone regeneration (GBR) is a surgical technique involving bone grafts and barrier membranes to repair minor defects near dental implants. GBR is frequently performed alongside the placement of titanium implants. The main objective of GBR is to prevent non-osteogenic tissues from hindering bone regeneration by applying a membrane. This method enhances hard and soft tissues in the periodontal attachment. GBR plays a crucial role in ensuring proper functionality, aesthetics, and prosthetic rehabilitation.
Guided Bone Regeneration Market- Market Dynamics
Rising Demand For Dental Implantology Procedures is expected to propel market demand
GBR techniques, which utilize barrier membranes and bone graft materials to stimulate bone regeneration around dental implants, play a critical role in ensuring the success of implant placements, particularly in situations where there is insufficient bone volume. The World Health Organization (WHO) has projected that by 2023, 15% of middle-aged adults (35-44 years) will be affected by severe dental disease leading to tooth loss. Additionally, 9% of dental implant cases involve patients between 65-74 years old. It is worth noting that 93% of all dental implants in the U.S. are made of titanium, as reported by the National Center for Biotechnology Information. Moreover, the market is expected to experience growth opportunities due to advancements in Regenerative Medicine and innovations in GBR materials. However, the high cost of procedures may pose a challenge to market growth.
Guided Bone Regeneration Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.69% over the forecast period (2024-2032)
Based on Type segmentation, Barrier Membranes was predicted to show maximum market share in the year 2023
Based on End-User segmentation, Dental Clinics was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Guided Bone Regeneration Market is segmented based on Type, Application, End-User, and Region.
The market is segmented into two groups according to Type: Bone Graft Substitutes and Barrier Membranes. Barrier Membranes are the leading category in the market. They are essential in guided bone regeneration (GBR) as they create a barrier that hinders soft tissue from growing into the bone defect site, thus facilitating the formation of new bone.
The market is segmented into three categories according to Application: Implantology, Periodontology, Oral and Maxillofacial Surgery, and Other areas. The guided bone regeneration market, fueled by its wide range of uses in Implantology, periodontology, oral and maxillofacial surgery, and other fields, is set for substantial expansion.
The market is segmented into four sectors according to End-User: Hospitals, Dental Clinics, Academic and Research Centers, and Ambulatory Surgical Centers. Dental Clinics lead the market. They are important consumers of GBR solutions, utilizing barrier membranes to promote bone regeneration and enhance patient results.
Guided Bone Regeneration Market- Geographical Insights
Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is predominantly led by North America, attributed to the high incidence of oral diseases and the increasing awareness among patients. Even though adults today are losing fewer teeth compared to previous generations, the overall oral health of American adults has not significantly improved over the past two decades. Tooth decay, affecting 90% of adults aged 20 to 64 years, and gum disease, affecting nearly 50% of adults aged 45 to 64 years, continue to be prevalent oral health issues as indicated by Oral Health in America. The rising awareness among patients regarding oral health and the advantages of preventive and restorative dental procedures are driving the demand for GBR. Europe follows as the second largest region for market growth, owing to advancements in Regenerative Medicine.
The market for Guided Bone Regeneration (GBR) is fiercely competitive, as many companies strive to offer cutting-edge solutions for improving bone regeneration in dental and orthopedic settings. These companies dedicate significant resources to research and development to create superior GBR materials that boast improved biocompatibility, resorption rates, and user-friendliness. Additionally, extensive clinical trials are conducted by companies to showcase the effectiveness and safety of their GBR products.
Baxter International Inc., a prominent global player in the field of surgical innovation, has recently revealed that the U.S. Food and Drug Administration (FDA) has approved Altapore Shape Bioactive Bone Graft. This new product is the most recent offering in the company's advanced line of bone graft substitutes.
Medtronic plc has revealed that the U.S. FDA has approved a new prospective, randomized pivotal clinical trial for the utilization of Infuse Bone Graft in Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures. TLIF is a surgical procedure that involves fusing the bones of the spine through a posterior approach, and it is commonly used to address specific painful conditions in the lumbar region of the spine.
GLOBAL GUIDED BONE REGENERATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Baxter International Inc.
Medtronic
Stryker Corp.
Integra Lifesciences
Zimmer Biomet Holdings
Dentsply Sirona
Botiss Biomaterials Gmbh
Geistlich Pharma AG
Biotech Dental
Dentegris Gmbh
GENOSS Co. Ltd.
Osstem Implant
Others